Quest Diagnostics Incorporated Company Profile (NYSE:DGX)

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated logoQuest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Company's Diagnostic Information Services business develops and delivers diagnostic testing information and services to patients, physicians, health plans, hospitals, accountable care organizations (ACOs), integrated delivery networks (IDNs), other commercial laboratories, employers and others. The Company's Diagnostic Solutions offers a range of solutions for insurers and healthcare providers. The Company provides risk assessment services for the life insurance industry. In addition, the Company offers healthcare organizations and clinicians' health information technology solutions and diagnostic products. ExamOne provides risk assessment services to the life insurance industry in North America. ChartMaxx is the Company's enterprise content management system for hospitals.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Health Care Services
  • Exchange: NYSE
  • Symbol: DGX
  • CUSIP: 74834L10
Key Metrics:
  • Previous Close: $95.60
  • 50 Day Moving Average: $92.93
  • 200 Day Moving Average: $87.27
  • 52-Week Range: $65.06 - $96.45
  • Trailing P/E Ratio: 21.20
  • Foreward P/E Ratio: 16.54
  • P/E Growth: 2.13
  • Market Cap: $13.10B
  • Outstanding Shares: 137,000,000
  • Beta: 0.68
  • Net Margins: 8.56%
  • Return on Equity: 14.61%
  • Return on Assets: 6.71%
  • Debt-to-Equity Ratio: 0.80%
  • Current Ratio: 1.56%
  • Quick Ratio: 1.48%
Additional Links:
Companies Related to Quest Diagnostics Incorporated:

Analyst Ratings

Consensus Ratings for Quest Diagnostics Incorporated (NYSE:DGX) (?)
Ratings Breakdown: 3 Sell Ratings, 9 Hold Ratings, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $89.32 (6.57% downside)

Analysts' Ratings History for Quest Diagnostics Incorporated (NYSE:DGX)
DateFirmActionRatingPrice TargetDetails
1/26/2017Canaccord GenuitySet Price TargetBuy$102.00View Rating Details
1/27/2017Jefferies Group LLCBoost Price TargetHold$86.00 -> $96.00View Rating Details
1/18/2017Deutsche Bank AGReiterated RatingBuy$108.00View Rating Details
12/12/2016Goldman Sachs Group, Inc. (The)UpgradeNeutral -> Buy$102.00View Rating Details
11/30/2016MizuhoReiterated RatingNeutral$88.00View Rating Details
11/14/2016Barclays PLCSet Price TargetHold$85.00View Rating Details
11/14/2016Bank of America CorpReiterated RatingSell$78.00View Rating Details
9/9/2016Citigroup Inc.Initiated CoverageNeutral$86.00View Rating Details
7/24/2016Evercore ISIReiterated RatingHold$78.50 -> $89.50View Rating Details
6/24/2016Jyske BankDowngradeNeutral -> SellView Rating Details
6/7/2016Morgan StanleyReiterated RatingSellView Rating Details
5/24/2016Credit Suisse GroupReiterated RatingHoldView Rating Details
5/22/2016KeyCorpReiterated RatingHoldView Rating Details
5/16/2016Robert W. BairdReiterated RatingHoldView Rating Details
4/22/2016Royal Bank Of CanadaBoost Price TargetSector Perform$70.00 -> $76.00View Rating Details
1/29/2016William BlairReiterated RatingHoldView Rating Details
10/16/2015Wells Fargo & CompanyUpgradeUnderperform -> Market PerformView Rating Details
3/27/2015JMP SecuritiesInitiated CoverageMarket PerformView Rating Details
(Data available from 2/22/2015 forward)


Earnings History for Quest Diagnostics Incorporated (NYSE:DGX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/26/2017Q416$1.27$1.31$1.86 billion$1.86 billionViewListenView Earnings Details
10/20/2016Q316$1.35$1.37$1.53 billion$1.89 billionViewListenView Earnings Details
7/21/2016Q216$1.32$1.34$1.91 billion$1.91 billionViewListenView Earnings Details
4/21/2016Q116$1.12$1.12$1.82 billion$1.86 billionViewListenView Earnings Details
1/28/2016Q415$1.19$1.19$1.85 billion$1.85 billionViewListenView Earnings Details
10/22/2015Q315$1.26$1.28$1.89 billion$1.88 billionViewListenView Earnings Details
7/23/2015Q215$1.23$1.25$1.93 billion$1.93 billionViewListenView Earnings Details
4/23/2015Q115$1.04$1.05$1.85 billion$1.84 billionViewListenView Earnings Details
1/29/2015Q414$1.04$1.08$1.85 billion$1.90 billionViewListenView Earnings Details
10/23/2014Q314$1.08$1.10$1.87 billion$1.90 billionViewListenView Earnings Details
7/24/2014Q214$1.06$1.08$1.88 billion$1.90 billionViewN/AView Earnings Details
4/24/2014Q114$0.89$0.84$1.75 billion$1.75 billionViewListenView Earnings Details
1/30/2014Q413$0.93$0.97$1.74 billion$1.76 billionViewListenView Earnings Details
10/17/2013Q313$1.20$1.02$1.84 billion$1.79 billionViewListenView Earnings Details
7/18/2013Q2 2013$1.10$1.06$1.84 billion$1.82 billionViewListenView Earnings Details
4/17/2013Q1 2013$1.03$0.89$1.86 billion$1.80 billionViewListenView Earnings Details
1/23/2013Q4 2012$1.02$1.01$1.83 billion$1.77 billionViewListenView Earnings Details
10/17/2012$1.18$1.18ViewN/AView Earnings Details
7/19/2012$1.17$1.17ViewN/AView Earnings Details
4/18/2012$1.01$1.07ViewN/AView Earnings Details
1/24/2012$1.06$1.23ViewN/AView Earnings Details
10/25/2011$1.11$1.18ViewN/AView Earnings Details
7/20/2011$1.12$1.12ViewN/AView Earnings Details
4/20/2011$1.01$1.00ViewN/AView Earnings Details
1/25/2011$0.91$0.98ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Quest Diagnostics Incorporated (NYSE:DGX)
Current Year EPS Consensus Estimate: $5.47 EPS
Next Year EPS Consensus Estimate: $5.78 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$1.00$1.15$1.09
Q2 20165$1.31$1.33$1.32
Q3 20165$1.33$1.39$1.36
Q4 20165$1.26$1.29$1.27
Q1 20174$1.16$1.22$1.18
Q2 20174$1.39$1.44$1.41
Q3 20174$1.42$1.45$1.44
Q4 20174$1.37$1.41$1.39
(Data provided by Zacks Investment Research)


Current Dividend Information for Quest Diagnostics Incorporated (NYSE:DGX)
Annual Dividend:$1.80
Dividend Yield:1.88%
Dividend Growth:9.60% (3 Year Average)
Payout Ratio:40.00% (Based on Trailing 12 Months of Earnings)
32.91% (Based on Current Year Consensus EPS Estimate)
31.14% (Based on Next Year Consensus EPS Estimate)
Track Record:5 Years of Consecutive Dividend Growth

Dividend History for Quest Diagnostics Incorporated (NYSE:DGX)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Quest Diagnostics Incorporated (NYSE:DGX)
Insider Ownership Percentage: 1.50%
Institutional Ownership Percentage: 87.71%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/30/2017Catherine T DohertySVPSell80,000$90.58$7,246,400.00View SEC Filing  
8/19/2016Jenne K BritellDirectorSell4,000$84.76$339,040.00View SEC Filing  
8/10/2016Jenne K BritellDirectorSell4,000$85.20$340,800.00View SEC Filing  
8/3/2016Jeffrey M LeidenDirectorSell6,345$85.62$543,258.90View SEC Filing  
7/25/2016John B. ZieglerDirectorSell1,000$84.36$84,360.00View SEC Filing  
5/27/2016Catherine T DohertySVPSell47,334$77.27$3,657,498.18View SEC Filing  
5/12/2016Jenne K BritellDirectorSell8,000$75.68$605,440.00View SEC Filing  
5/9/2016Everett CunninghamSVPSell56,312$76.26$4,294,353.12View SEC Filing  
5/6/2016Everett CunninghamSVPSell50,447$76.00$3,833,972.00View SEC Filing  
4/25/2016Catherine T DohertySVPSell29,550$74.45$2,199,997.50View SEC Filing  
3/3/2015Michael E PrevoznikSVPSell3,261$71.16$232,052.76View SEC Filing  
2/11/2015Daniel StanzioneDirectorSell8,000$70.97$567,760.00View SEC Filing  
2/4/2015Gail R WilenskyDirectorSell8,000$72.34$578,720.00View SEC Filing  
2/3/2015John B ZieglerDirectorSell8,000$71.88$575,040.00View SEC Filing  
2/2/2015Thomas F BongiornoVPSell3,000$71.50$214,500.00View SEC Filing  
11/17/2014Jon R CohenSVPSell160,029$63.13$10,102,630.77View SEC Filing  
8/8/2014Catherine T DohertySVPSell25,000$60.12$1,503,000.00View SEC Filing  
8/4/2014Michael E PrevoznikSVPSell14,377$61.01$877,140.77View SEC Filing  
7/30/2014Jenne K BritellDirectorSell8,000$62.37$498,960.00View SEC Filing  
7/30/2014Michael E PrevoznikSVPSell16,384$62.51$1,024,163.84View SEC Filing  
7/29/2014John C Md BaldwinDirectorSell8,000$62.31$498,480.00View SEC Filing  
7/28/2014Thomas F BongiornoVPSell4,000$61.72$246,880.00View SEC Filing  
7/25/2014John B ZieglerDirectorSell8,000$61.90$495,200.00View SEC Filing  
5/22/2014John ZieglerDirectorSell2,973$57.65$171,393.45View SEC Filing  
5/7/2014Gary PfeifferDirectorSell10,000$55.95$559,500.00View SEC Filing  
5/5/2014Mark GuinanCFOBuy4,000$55.51$222,040.00View SEC Filing  
2/27/2014Jenne BritellDirectorSell10,000$52.74$527,400.00View SEC Filing  
2/19/2014Michael PrevoznikSVPSell2,860$52.26$149,463.60View SEC Filing  
2/18/2014Gail WilenskyDirectorSell30,000$52.93$1,587,900.00View SEC Filing  
2/6/2014Timothy MainDirectorBuy5,000$50.71$253,550.00View SEC Filing  
11/5/2013Thomas F BongiornoVPSell16,667$62.49$1,041,520.83View SEC Filing  
10/29/2013Thomas F BongiornoVPSell6,000$59.00$354,000.00View SEC Filing  
10/25/2013Gary M PfeifferDirectorSell2,000$58.10$116,200.00View SEC Filing  
9/17/2013Catherine DohertySVPSell43,334$62.00$2,686,708.00View SEC Filing  
8/14/2013Catherine DohertySVPSell33,000$59.85$1,975,050.00View SEC Filing  
8/12/2013John ZieglerDirectorSell1,953$59.45$116,105.85View SEC Filing  
8/8/2013Thomas BongiornoVPSell10,864$59.33$644,561.12View SEC Filing  
7/23/2013Jenne K BritellDirectorSell4,200$58.99$247,758.00View SEC Filing  
6/18/2013Michael E PrevoznikSVPSell126,667$62.64$7,934,420.88View SEC Filing  
5/22/2013John B ZieglerDirectorSell31,362$62.00$1,944,444.00View SEC Filing  
5/14/2013John C Md BaldwinDirectorSell1,214$59.41$72,123.74View SEC Filing  
4/11/2013John B ZieglerDirectorSell1,470$58.35$85,774.50View SEC Filing  
1/17/2013Gary M PfeifferDirectorSell10,000$60.00$600,000.00View SEC Filing  
10/3/2012Robert HagemannCFOSell46,667$64.00$2,986,688.00View SEC Filing  
8/7/2012Stephen H RusckowskiCEOBuy5,000$59.34$296,700.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Quest Diagnostics Incorporated (NYSE:DGX)
News IconApril 21st Options Now Available For Quest Diagnostics (NYSE:DGX) - February 22 at 5:33 AM logoQuest Diagnostics Declares Quarterly Cash Dividend (NYSE:DGX) - February 22 at 5:33 AM
News IconThe Charts For Quest Diagnostics Incorporated (DGX) Is Speaking Volumes Today - NY Stock News (NYSE:DGX) - February 18 at 4:27 PM logoQuest Diagnostics : Named One of 2017 "World's Most Admired Companies" by Fortune Magazine (NYSE:DGX) - February 16 at 7:39 PM logoQuest Diagnostics Named One of 2017 "World's Most Admired Companies" by Fortune Magazine (NYSE:DGX) - February 16 at 7:39 PM logoQuest Diagnostics Named One of 2017 "World's Most Admired Companies" by Fortune Magazine (NYSE:DGX) - February 16 at 7:39 PM logoQuest Diagnostics : PeaceHealth to sell its lab services, including in Bellingham (NYSE:DGX) - February 16 at 2:38 PM logoQuest Diagnostics and PeaceHealth to Increase Access to Innovative, High-Value Laboratory Services in the Pacific Northwest (NYSE:DGX) - February 16 at 2:38 PM logoQuest Diagnostics: Harvard Pilgrim Health Care Partners with Physicians to Close Costly Gaps in Care (NYSE:DGX) - February 16 at 2:38 PM logo3 Dividend Stocks for 2017 (NYSE:DGX) - February 13 at 5:25 PM logoQuest Diagnostics Stock Sees Short Interest Decrease By 24.2% (NYSE:DGX) - February 10 at 5:07 PM logoQuest Diagnostics Partners with Veracyte for Cancer Testing (NYSE:DGX) - February 9 at 5:13 PM logoVeracyte to Expand Patient Access to the Afirma® Gene Expression Classifier In Thyroid Cancer Diagnosis Through Agreement with Quest Diagnostics (NYSE:DGX) - February 8 at 5:10 PM
News IconMedical Laboratories & Research: Quest Diagnostics Incorporated (NYSE:DGX) Position of the day (NYSE:DGX) - February 7 at 10:53 PM logoResearch Analysts Set Quest Diagnostics Incorporated (NYSE:DGX) Price Target at $90.75 - (NYSE:DGX) - February 7 at 5:53 PM
News IconLeading stocks in today’s market: Quest Diagnostics Incorporated (NYSE:DGX) (NYSE:DGX) - February 4 at 4:53 PM
News IconQuest Diagnostics Incorporated (NYSE:DGX) from Medical Laboratories & Research – Todays Top Gains (NYSE:DGX) - February 3 at 10:04 PM logoThis simple blood test promises to improve your athletic training. We put it to the test (NYSE:DGX) - February 3 at 5:01 PM
News IconQ1 2017 Earnings Forecast for Quest Diagnostics Incorporated (DGX) Issued By KeyCorp (NYSE:DGX) - February 2 at 5:10 PM
News IconEarnings Forecast Research on Quest Diagnostics Incorporated (DGX) (NYSE:DGX) - February 2 at 5:10 PM logoETFs with exposure to Quest Diagnostics, Inc. : February 2, 2017 (NYSE:DGX) - February 2 at 5:10 PM logoQuest Diagnostics Reaches Analyst Target Price (NYSE:DGX) - February 1 at 10:39 AM
News IconTop Gainers of the Day: Quest Diagnostics Incorporated (NYSE:DGX) from Medical Laboratories & Research (NYSE:DGX) - January 31 at 5:21 PM logoQuest Diagnostics, Inc. breached its 50 day moving average in a Bearish Manner : DGX-US : January 31, 2017 (NYSE:DGX) - January 31 at 5:21 PM logoQuest Diagnostics, Inc. :DGX-US: Earnings Analysis: 2016 By the Numbers : January 30, 2017 (NYSE:DGX) - January 30 at 10:44 AM
News IconReviewing Individual Broker Targets Of Quest Diagnostics Incorporated (NYSE:DGX) (NYSE:DGX) - January 28 at 9:58 PM
News IconQuest Diagnostics Incorporated (DGX) Posts Earnings Results, Beats Estimates By $0.04 EPS (NYSE:DGX) - January 28 at 9:58 PM
News IconSummary of Analyst's Beliefs: Quest Diagnostics Incorporated's (DGX) (NYSE:DGX) - January 28 at 4:56 PM
News IconNext Weeks Broker Price Targets For Quest Diagnostics Incorporated (NYSE:DGX) (NYSE:DGX) - January 27 at 11:17 PM
News IconThe Quest Diagnostics Inc. (DGX) to Release Quarterly Earnings on Thursday (NYSE:DGX) - January 27 at 11:16 PM
News IconQuest Diagnostics Inc (DGX) Releases Earnings Results, Beats Expectations By $0.04 EPS (NYSE:DGX) - January 27 at 11:16 PM
News IconWhat makes Quest Diagnostics Incorporated (DGX) a good dividend stock? (NYSE:DGX) - January 27 at 11:16 PM logoCincinnati Financial Becomes #74 Most Shorted S&P 500 Component, Replacing Quest Diagnostics (NYSE:DGX) - January 26 at 10:54 PM logoQuest Diagnostics Sees Higher FY17 Results; Joins With Montefiore Health System (NYSE:DGX) - January 26 at 10:54 PM logoQuest Diagnostics Incorporated (NYSE:DGX) Files An 8-K Results of Operations and Financial Condition (NYSE:DGX) - January 26 at 10:54 PM logoQuest Diagnostics Reports Fourth Quarter And Full Year 2016 Financial Results; Provides Guidance For Full Year 2017 (NYSE:DGX) - January 26 at 10:54 PM logo6:51 am Quest Diagnostics beats by $0.04, reports revs in-line; guides FY17 EPS in-line, revs above consensus (NYSE:DGX) - January 26 at 10:54 PM logoQUEST DIAGNOSTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh (NYSE:DGX) - January 26 at 10:54 PM logoQ4 2016 Quest Diagnostics Inc Earnings Release - Before Market Open (NYSE:DGX) - January 26 at 10:54 PM logoQuest Diagnostics tops 4Q profit forecasts (NYSE:DGX) - January 26 at 10:54 PM logoQuest Diagnostics (DGX): Tops Q4 Earnings, Sales in Line (NYSE:DGX) - January 26 at 10:54 PM logoQuest Diagnostics Inc Earnings Call scheduled for 8:30 am ET today (NYSE:DGX) - January 26 at 10:54 PM logoEdited Transcript of DGX earnings conference call or presentation 26-Jan-17 1:30pm GMT (NYSE:DGX) - January 26 at 10:54 PM
News IconQuest Diagnostics Incorporated (NYSE:DGX) to Post $1.27 Earnings Per Share: Analysts - Wall Street Beacon (NYSE:DGX) - January 26 at 5:54 PM logoQuest Diagnostics Incorporated's (DGX) CEO Stephen Rusckowski on Q4 2016 Results - Earnings Call Transcript - Seeking Alpha (NYSE:DGX) - January 26 at 5:54 PM
News IconQuest Diagnostics Incorporated DGX Medical Equipment Deals and Alliances Profile Prices from USD $250 (NYSE:DGX) - January 25 at 5:53 PM logoShould You Buy Quest Diagnostics (DGX) Ahead of Earnings? (NYSE:DGX) - January 25 at 5:53 PM logoDGX March 17th Options Begin Trading (NYSE:DGX) - January 23 at 5:02 PM logoQuest Diagnostics : Launches Nation's First Hepatitis B Virus Quantitative Test to Help Assess Response to Antiviral Therapy (NYSE:DGX) - January 18 at 5:03 PM logoQuest Diagnostics Launches Nation's First Hepatitis B Virus Quantitative Test to Help Assess Response to Antiviral Therapy (NYSE:DGX) - January 18 at 5:03 PM


What is Quest Diagnostics Incorporated's stock symbol?

Quest Diagnostics Incorporated trades on the New York Stock Exchange (NYSE) under the ticker symbol "DGX."

How often does Quest Diagnostics Incorporated pay dividends? What is the dividend yield for Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated declared a quarterly dividend on Tuesday, February 21st. Investors of record on Wednesday, April 5th will be given a dividend of $0.45 per share on Wednesday, April 19th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 1.88%. The ex-dividend date is Monday, April 3rd.

Where is Quest Diagnostics Incorporated's stock going? Where will Quest Diagnostics Incorporated's stock price be in 2017?

15 brokers have issued 1 year price objectives for Quest Diagnostics Incorporated's stock. Their predictions range from $72.00 to $108.00. On average, they anticipate Quest Diagnostics Incorporated's share price to reach $89.32 in the next twelve months.

When will Quest Diagnostics Incorporated announce their earnings?

Quest Diagnostics Incorporated is scheduled to release their next quarterly earnings announcement on Wednesday, April, 19th 2017.

What are analysts saying about Quest Diagnostics Incorporated stock?

Here are some recent quotes from research analysts about Quest Diagnostics Incorporated stock:

  • According to Zacks Investment Research, "Quest Diagnostics’ fourth-quarter 2016 earnings exceeded the Zacks Consensus Estimate while revenues remained in line. The company has witnessed significant growth through infectious disease testing, prescription drug monitoring and wellness business. We expect these growth drivers to be active through the coming quarter as well. In this regard, over the past three months, Quest Diagnostics has traded above the Zacks categorized Medical - Outpatient and Home Healthcare industry. The upside is backed by the successful execution of the company’s strategy to grow its esoteric testing and drive profitable growth. Within prescription drug monitoring, the company currently has two new Zika tests that are awaiting FDA clearance. The company also piloted a noninvasive prenatal screening program to serve women of average risk. We are also looking forward to the company's latest alliance with Ancestry and IBM." (1/30/2017)

  • Jefferies Group LLC analysts commented, "We are maintaining our Hold on DGX given our view that significant multiple expansion is unlikely from its current 10-year high P/E. That said, we do not expect its valuation to crack either given the company's stable fundamentals, the emerging opportunity with hospital labs, consistent dividend & buybacks, potential upside from US tax reform, and the composition of its shareholder base." (1/27/2017)

Who owns Quest Diagnostics Incorporated stock?

Quest Diagnostics Incorporated's stock is owned by a variety of of institutional and retail investors. Top institutional investors include State Street Corp (4.92%), Bessemer Group Inc. (1.76%), Allianz Asset Management AG (1.76%), Investec Asset Management LTD (1.48%), Dimensional Fund Advisors LP (1.40%) and AQR Capital Management LLC (0.93%). Company insiders that own Quest Diagnostics Incorporated stock include Catherine T Doherty, Everett Cunningham, Jeffrey M Leiden, Jenne K Britell, John B Ziegler and Michael E Prevoznik.

Who sold Quest Diagnostics Incorporated stock? Who is selling Quest Diagnostics Incorporated stock?

Quest Diagnostics Incorporated's stock was sold by a variety of institutional investors in the last quarter, including Allianz Asset Management AG, FMR LLC, Two Sigma Investments LP, Paradigm Asset Management Co. LLC, Federated Investors Inc. PA, Investec Asset Management LTD, Davis Selected Advisers and Pinnacle Associates Ltd.. Company insiders that have sold Quest Diagnostics Incorporated stock in the last year include Catherine T Doherty, Everett Cunningham, Jeffrey M Leiden, Jenne K Britell and John B Ziegler.

Who bought Quest Diagnostics Incorporated stock? Who is buying Quest Diagnostics Incorporated stock?

Quest Diagnostics Incorporated's stock was acquired by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., State Street Corp, Janus Capital Management LLC, Bessemer Group Inc., Asset Management One Co. Ltd., AMF Pensionsforsakring AB, Cipher Capital LP and Elkfork Partners LLC.

How do I buy Quest Diagnostics Incorporated stock?

Shares of Quest Diagnostics Incorporated can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Quest Diagnostics Incorporated stock cost?

One share of Quest Diagnostics Incorporated stock can currently be purchased for approximately $95.60.

Quest Diagnostics Incorporated (NYSE:DGX) Chart for Wednesday, February, 22, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Quest Diagnostics Incorporated (NYSE:DGX)

Earnings History Chart

Earnings by Quarter for Quest Diagnostics Incorporated (NYSE:DGX)

Dividend History Chart

Dividend Payments by Quarter for Quest Diagnostics Incorporated (NYSE:DGX)

Last Updated on 2/22/2017 by Staff